Identification of mitophagy-related biomarkers in human rheumatoid arthritis using machine learning models
Artificial Cells, Nanomedicine, and Biotechnology · Published 2025-07-16 · DOI 10.1080/21691401.2025.2533361
Free full text
Authors being retrieved — see the publisher record. https://doi.org/10.1080/21691401.2025.2533361
Abstract
Rheumatoid arthritis (RA) is a systemic immune-mediated disease characterized by synovitis and joint cartilage destruction. Although many studies have shown that mitophagy is crucial in the development of bone metabolism disorders, its exact function in rheumatoid arthritis (RA) is still not well understood. This study analysed the GSE77298 dataset from the Gene Expression Omnibus (GEO) to identify differentially expressed genes (DEGs) between rheumatoid arthritis (RA) patients and healthy controls. Mitophagy-related genes (MRGs) were extracted from the literature and screened using bioinformatics techniques, resulting in differentially expressed MRGs (DE-MRGs). The diagnostic value of these genes was assessed using receiver operating characteristic (ROC) curves, and an ANN model was constructed. In the GSE77298 dataset, 267 differentially expressed genes (DEGs) were identified. Weighted gene co-expression network analysis (WGCNA) identified 2191 key module genes, leading to 63 DE-MRGs. Two MRGs, TMEM45A and ZBTB25, were identified as hub genes with areas under the curve (AUC) of 0.991 and 0.911, respectively. The nomogram model demonstrated high diagnostic value. Mitophagy plays a critical role in the progression of rheumatoid arthritis (RA). Identifying two genes associated with mitophagy may aid in the early diagnosis, mechanistic understanding, and treatment of RA.
Abstract from DOAJ. Public domain (CC0 1.0).
Read the article at the publisher →
Publication details
- Year
- 2025
Related articles
- Molecular mechanisms of phytochemicals from Zanthoxylum nitidum (Roxb.) DC. against hepatocellular carcinoma: insights from network pharmacology, molecular docking, and bioinformatics · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Antimicrobial properties and bioactivity of zirconia-based biocomposites · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Human tendon stem/progenitor cell-derived extracellular vesicle production promoted by dynamic culture · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Characterization of genipin-crosslinked gelatin/PVA hydrogels and the chondroprotective influence of hydroxytyrosol: an In vitro study · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Multi-omics analysis of the potential association between ageing and rheumatoid arthritis and screening of potential therapeutic targets · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Cross-talk between diabetic nephropathy and bone loss: PBMCs-guided discovery of NLRP3-inflammatory signalling · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Exosome-mediated perturbation of the immune-bone metabolism axis: a mechanistic investigation into bone loss in a simulated microgravity environment · Artificial Cells, Nanomedicine, and Biotechnology · 2025 · Same journal
- Bio-Inspired lipid nanovesicles (iNVs) incorporating membrane proteins from healthy tendon stem cells for targeted protein restoration in tendinopathic in vitro model · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Novel anti-rheumatic potential of Eucalrobusone C: inhibition of rheumatoid arthritis fibroblast-like synoviocytes and metabolic reprogramming · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal
- Engineering nanobodies for drug delivery systems in Alzheimer’s disease · Artificial Cells, Nanomedicine, and Biotechnology · 2026 · Same journal